ACER THERAPEUTICS INC.

Profile

Company Names

ACER THERAPEUTICS INC.

Addresses

222 THIRD STREET, SUITE 2240, CAMBRIDGE, MA 02142

Phone Numbers

617-225-7700

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$29,049,383.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2017-09-19 
$15,674,384.00 
$15,674,384.00 
$0.00 
Equity 
3
2017-03-22 
$3,125,000.00 
$5,500,000.00 
$2,375,000.00 
Debt 
2
2016-04-21 
$8,149,999.00 
$8,149,999.00 
$0.00 
Equity 
1
2015-03-20 
$2,100,000.00 
$2,100,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEPHEN 
 
ASELAGE 
DIRECTOR
RETROPHIN, INC.   |  ACER THERAPEUTICS INC.   |  ACER THERAPEUTICS INC.
HUBERT 
 
BIRNER 
DIRECTOR
HORIZON PHARMA, INC.   |  ARGOS THERAPEUTICS INC   |  PROTEON THERAPEUTICS INC   |  ACER THERAPEUTICS INC.
JOHN 
 
DUNN 
DIRECTOR
PASSIONATE PET, INC.   |  SHACK 3, LLC   |  ACER THERAPEUTICS INC.   |  BANYAN OPPORTUNITY FUND IMN, LLC   |  BANYAN OPPORTUNITY FUND RCA, LLC   |  BOF III SI, LLC
CYNTHIA 
 
LAVOIE 
DIRECTOR
ZELOS THERAPEUTICS INC   |  ACER THERAPEUTICS INC.
LUC 
 
MARENGERE 
DIRECTOR
COLUCID PHARMACEUTICALS, INC.   |  ACER THERAPEUTICS INC.   |  RAPID MICRO BIOSYSTEMS, INC.   |  ACCESS VASCULAR, INC.   |  SARKANA PHARMA, INC.   |  VEKTOR MEDICAL, INC.   |  EGG MEDICAL, INC.
HARRY 
 
PALMIN 
PROMOTER
ACER THERAPEUTICS INC.
HARRY 
S. 
PALMIN 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
NOVELOS THERAPEUTICS, INC.   |  ACER THERAPEUTICS INC.   |  ACER THERAPEUTICS INC.
CHRISTOPHER 
 
SCHELLING 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ACER THERAPEUTICS INC.   |  CASCADE PRODRUG INC.
ROBERT 
 
STEINER 
EXECUTIVE OFFICER
WATERSMART SOFTWARE, INC.   |  ACER THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-10-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-19 
2017-04-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2017-03-22 
2016-05-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-21 
2016-05-06
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-21 
2015-04-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2015-03-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
PIPER JAFFRAY + CO.
665